Gastrointestinal (GI) side effects of retatrutide are similar to those of semaglutide and other GLP-1 medications
Discussion In this article, we reviewed pre-clinical and mechanistic studies (in vitro, in animal and in human) and clinical studies, leveraging potential translational aspects, on GLP-1RAs across a variety of cognitive and mental health disorders
In addition, they have been shown to enhance synaptic transmission and counteract learning deficits (30, 31)
Success requires ingredient partners who understand not only the science of satiety and nutrition, but also the technical requirements of commercial food production
Symptoms and clinical follow-up remain essential
You might have read about GLP-1 drugs and wondered whether they might be a good option for you